Novo Nordisk A S NVO
NYSE NVO
$46.74 +0.60 (+1.30%)
At close: Aug 21, 2026 · 4:02 PM EDT

Novo Nordisk A S (NVO) Capital Expenditures (2012 - 2016)

Novo Nordisk A S's (NVO) quarterly Capital Expenditures came in at $254.0 million in Q2 2016, up 68.21% YoY from $151.0 million in Q3 2015, and up 57.76% on a QoQ basis from $161.0 million in Q1 2016.

Novo Nordisk A S (NVO) Capital Expenditures (2012 - 2016) Analysis & Trends

Novo Nordisk A S (NVO) has 5 years of Capital Expenditures data on file, last reported at $254.0 million in Q2 2016.

Peer Comparison

Historic Data

Download Data
DateValue
Jun 30, 2016 254.00 Mn
Jun 30, 2016 254.00 Mn
Mar 31, 2016 161.00 Mn
Mar 31, 2016 161.00 Mn
Dec 31, 2015 322.00 Mn
Dec 31, 2015 322.00 Mn
Sep 30, 2015 186.00 Mn
Sep 30, 2015 186.00 Mn
Jun 30, 2015 151.00 Mn
Jun 30, 2015 151.00 Mn
Mar 31, 2015 115.00 Mn
Mar 31, 2015 115.00 Mn
Dec 31, 2014 259.00 Mn
Dec 31, 2014 259.00 Mn
Sep 30, 2014 176.00 Mn
Sep 30, 2014 176.00 Mn
Jun 30, 2014 148.00 Mn
Jun 30, 2014 148.00 Mn
Mar 31, 2014 127.00 Mn
Mar 31, 2014 127.00 Mn